SciVision Biotech Inc
TWSE:1786
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SciVision Biotech Inc
TWSE:1786
|
TW |
Multiples-Based Value
The Multiples-Based Value of one
SciVision Biotech Inc
stock under the Base Case scenario is
63.19
TWD.
Compared to the current market price of 60.7 TWD,
SciVision Biotech Inc
is
Undervalued by 4%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
SciVision Biotech Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
|
SciVision Biotech Inc
TWSE:1786
|
4.5B TWD | 5.1 | 28 | 14.7 | 20.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.2 | 37.2 | 26.9 | 32.3 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.4B CHF | 3.6 | 38.5 | 14.8 | 28.8 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
35.9B USD | 0 | 0 | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
99.8B DKK | 3.6 | 25.2 | 13.2 | 15.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.2B USD | 3 | 29.7 | 12.7 | 17.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
931.6B JPY | 7.2 | 52.7 | 25 | 33.9 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.8B USD | 1.1 | -16.2 | 17.2 | 55.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.8 | 11.5 | 18 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38.5B CNY | 8.5 | 23.3 | 20.9 | 20.9 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38B CNY | 3.9 | 22.3 | 33.1 | 33.1 |